Cargando…
The effect of ABO blood group and antibody class on the risk of COVID-19 infection and severity of clinical outcomes
The COVID-19 pandemic has affected more than 100 million cases and caused immense burdens on governments and healthcare systems worldwide. Since its emergence in December 2019, research has been focused on treating the infected, identifying those at risk and preventing spread. There is currently no...
Autores principales: | Almadhi, Marwa Ali, Abdulrahman, Abdulkarim, Alawadhi, Abdulla, Rabaan, Ali A., Atkin, Stephen, AlQahtani, Manaf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952683/ https://www.ncbi.nlm.nih.gov/pubmed/33707451 http://dx.doi.org/10.1038/s41598-021-84810-9 |
Ejemplares similares
-
Quarantining arriving travelers in the era of COVID-19: balancing the risk and benefits a learning experience from Bahrain
por: Abdulrahman, Abdulkarim, et al.
Publicado: (2021) -
Is glucose-6-phosphatase dehydrogenase deficiency associated with severe outcomes in hospitalized COVID-19 patients?
por: Kumar, Nitya, et al.
Publicado: (2021) -
The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19
por: Almadhi, Marwa Ali, et al.
Publicado: (2021) -
Clinical and Epidemiological Characteristics of COVID-19 in a Multi-National Cohort in the Middle East
por: Mallah, Saad I., et al.
Publicado: (2021) -
The Efficacy and Safety of Hydroxychloroquine in Patients with COVID-19: A Multicenter National Retrospective Cohort
por: Abdulrahman, Abdulkarim, et al.
Publicado: (2021)